AccessibilityHelpAbout Us
Spo Global logo

Spo Global(OTC) SPOM

Market Cap$474.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-100%
5 Year-99%
1 Year-57%
1 Month+0%
$0.00
+0.00%
+0.00Today
Spo Global last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-15
Spo Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-08
1 month+0%USD 0.002026-08-13
3 month+0%USD 0.002026-06-17
Year to date-40%USD 0.002025-12-31
1 year-57.14%USD 0.002025-09-15
3 year-90%USD 0.002023-09-15
5 year-98.8%USD 0.032021-09-16
Since inception-99.93%USD 0.402020-02-20

Spo Global Financials at a Glance

Market Cap

$474.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$192.43K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.78 (Low)

Price

$0.00

Volume

3,975

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Mar 31, 2009

SPOM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spo Global

SPO Global Inc. is a bio-pharmaceutical enterprise established in 2006 and headquartered in Jinan, China. The company specializes in developing and marketing a diverse range of healthcare products, including genetically coated stents, vaccines for Hepatitis B, and monoclonal antibodies for male infertility.

Products and Services
  • Genetically coated stents for cardiovascular applications
  • Vaccines targeting Hepatitis B virus (HBV)
  • Monoclonal antibodies for detecting male infertility
Growth Outlook
  • Recent quarterly cash flow showed a net increase of $743,363
  • Operating cash flow for Q2 2023 reached $731,646
  • Significant investments in property and equipment indicate future growth potential
Financial Highlights
  • Trailing twelve months (TTM) revenue of $243,358
  • Net income for Q1 2026 reported at -$20,867
  • Cash and cash equivalents at $3,358,653 as of Q3 2023
SPO Global Inc. operates in the technology sector, focusing on innovative healthcare solutions. The company has shown resilience in its cash flow management, with a notable increase in cash reserves over recent quarters. Despite facing challenges reflected in net income figures, the company’s strategic investments in its product lines and infrastructure suggest a commitment to long-term growth. The diverse portfolio of products positions SPO Global Inc. to capitalize on emerging healthcare needs, particularly in the bio-pharmaceutical space. Investors may find the company's focus on innovation and market expansion appealing as it navigates the complexities of the healthcare industry.
AI Generated • Sep 5, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Qiang Fang; Lian Jiang Peng

Website

www.spomedical.com

Headquarters

Orlando, FL 32810, US

SPOM Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

160.62%

Return on Capital

-22.21%

Return on Assets

-122.60%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$474.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.58B

Volume

3.98K

Avg. Volume

4.36M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$16.46K

EBITDA

-$16.46K

Operating Cash Flow

-$3.19M

Capital Expenditure

$4.40M

Free Cash Flow

$1.21M

Cash & ST Invst.

$17.22K

Total Debt

$275.56K

Spo Global Performance Analysis

Spo Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 3,119,819-90.2%
20232023-12-31USD 12,436,288298.6%
20242024-12-31USD 1,140,451-90.8%
20252025-12-31USD 243,358-78.7%
Spo Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-100.0%
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Spo Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.00-97.9%
20232023-12-31USD 0.012700.0%
20242024-12-31USD -0.00N/A
20252025-12-31USD -0.00-97.8%
Spo Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$474.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$67.84K

N/A

Employees

7

N/A

Net Income

-$6.69K

+54.9%

EBITDA

-$600.00

+93.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$17.22K

-99.5%

Total Debt

$275.56K

+1.4%

Accounts Receivable

$90.50K

-80.1%

Inventory

$49.23K

-97.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$275.56K

+1.4%

Return on Assets

-1.23%

N/A

Return on Invested Capital

13.74%

N/A

Free Cash Flow

$20.09K

-98.0%

Operating Cash Flow

$20.09K

-99.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BOMObowmo, Inc.
$0.00+0.00%
GAHCGlobal Arena Holding Inc.
$0.00+0.00%
AIADAiAdvertising, Inc.
$0.00+0.00%
UAMMUnited States Antimony Corporation
$0.00-4.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
VEEAVeea
$5.71+149.34%
BITOProShares Trust - ProShares Bitcoin ETF
$10.23-3.58%
NVDANvidia
$212.17+0.57%
INTCIntel
$97.14-0.05%

Questions About SPOM

What is the current price of Spo Global?

Spo Global is trading at $0.00 per share.

What is the 52-week range for Spo Global?

Over the past 52 weeks, Spo Global has traded between $0.00 and $0.00.

How much debt does Spo Global have?

As of the most recent reporting period, Spo Global reported total debt of $301.68K.

How much cash does Spo Global have on hand?

Spo Global reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Spo Global’s dividend yield?

Spo Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services